{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:50:11Z","timestamp":1793116211633,"version":"4.5.0"},"reference-count":151,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Minist\u00e9rio da Sa\u00fade, Departamento de Ci\u00eancia e Tecnologia","id":[{"id":"https:\/\/ror.org\/04p280284","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Histone deacetylases (HDACs) are crucial enzymes involved in the regulation of gene expression through chromatin remodeling, impacting numerous cellular processes, including cell proliferation, differentiation, and survival. In recent years, HDACs have emerged as therapeutic targets for neurodegenerative diseases (NDDs), such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease, given their role in modulating neuronal plasticity, neuroinflammation, and neuronal survival. HDAC inhibitors (HDACi) are small molecules that prevent the deacetylation of histones, thereby promoting a more relaxed chromatin structure and enhancing gene expression associated with neuroprotective pathways. Preclinical and clinical studies have demonstrated that HDACi can mitigate neurodegeneration, reduce neuroinflammatory markers, and improve cognitive and motor functions, positioning them as promising therapeutic agents for NDDs. Given the complexity and multifactorial nature of NDDs, therapeutic success will likely depend on multi-target drugs as well as new cellular and molecular therapeutic targets. Emerging evidence suggests that HDACi can modulate the function of astrocytes, a glial cell type critically involved in neuroinflammation, synaptic regulation, and the progression of neurodegenerative diseases. Consequently, HDACi targeting astrocytic pathways represent a novel approach in NDDs therapy. By modulating HDAC activity specifically in astrocytes, these inhibitors may attenuate pathological inflammation and promote a neuroprotective environment, offering a complementary strategy to neuron-focused treatments. This review aims to provide an overview of HDACs and HDACi in the context of neurodegeneration, emphasizing their molecular mechanisms, therapeutic potential, and limitations. Additionally, it explores the emerging role of astrocytes as targets for HDACi, proposing that this glial cell type could enhance the efficacy of HDACs-targeted therapies in NDD management.<\/jats:p>","DOI":"10.3390\/ph18101471","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:54:48Z","timestamp":1759229688000},"page":"1471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-4243","authenticated-orcid":false,"given":"Pedro","family":"Pinheiro","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Avalia\u00e7\u00e3o e S\u00edntese de Subst\u00e2ncias Bioativas, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2986-4043","authenticated-orcid":false,"given":"Luan","family":"Diniz","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Investiga\u00e7\u00e3o Metab\u00f3lica Associada ao Envelhecimento, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-3011","authenticated-orcid":false,"given":"Lucas","family":"Franco","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Avalia\u00e7\u00e3o e S\u00edntese de Subst\u00e2ncias Bioativas, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Siqueira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Neurobiologia Celular, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Gomes","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Neurobiologia Celular, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent Advances in Alzheimer\u2019s Disease: Mechanisms, Clinical Trials and New Drug Development Strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pathak, C., and Kabra, U.D. (2024). A Comprehensive Review of Multi-Target Directed Ligands in the Treatment of Alzheimer\u2019s Disease. Bioorg. Chem., 144.","DOI":"10.1016\/j.bioorg.2024.107152"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104052","DOI":"10.1016\/j.drudis.2024.104052","article-title":"Restoring the Epigenome in Alzheimer\u2019s Disease: Advancing HDAC Inhibitors as Therapeutic Agents","volume":"29","author":"Pereira","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shamsi, A., Shahwan, M., Zuberi, A., and Altwaijry, N. (2024). Identification of Potential Inhibitors of Histone Deacetylase 6 Through Virtual Screening and Molecular Dynamics Simulation Approach: Implications in Neurodegenerative Diseases. Pharmaceuticals, 17.","DOI":"10.3390\/ph17111536"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lee, S.Y., and Chung, W.-S. (2024). Astrocytic Crosstalk with Brain and Immune Cells in Healthy and Diseased Conditions. Curr. Opin. Neurobiol., 84.","DOI":"10.1016\/j.conb.2024.102840"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","article-title":"The Emerging Nature of Astrocyte Diversity","volume":"42","author":"Khakh","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuint.2014.07.008","article-title":"Astrocytic Control of Neural Circuit Formation: Highlights on TGF-Beta Signaling","volume":"78","author":"Diniz","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-neuro-112723-031738","article-title":"Heterogeneity of Astrocyte Reactivity","volume":"48","author":"Clayton","year":"2025","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Matias, I., Morgado, J., and Gomes, F.C.A. (2019). Astrocyte Heterogeneity: Impact to Brain Aging and Disease. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00059"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1111\/bph.16439","article-title":"Histone Deacetylase Inhibition Mitigates Cognitive Deficits and Astrocyte Dysfunction Induced by Amyloid-\u03b2 (A\u03b2) Oligomers","volume":"181","author":"Diniz","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41593-024-01580-z","article-title":"A Phenotypic Screening Platform for Identifying Chemical Modulators of Astrocyte Reactivity","volume":"27","author":"Clayton","year":"2024","journal-title":"Nat. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic Analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC Family: What Are the Cancer Relevant Targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2174\/1389557516666160428115959","article-title":"Beyond the Selective Inhibition of Histone Deacetylase 6","volume":"16","author":"Rodrigues","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e25720","DOI":"10.1002\/qua.25720","article-title":"Modeling Zinc-oxygen Coordination in Histone Deacetylase: A Comparison of Semiempirical Methods Performance","volume":"118","author":"Pinheiro","year":"2018","journal-title":"Int. J. Quantum Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","article-title":"Essential Function of Histone Deacetylase 1 in Proliferation Control and CDK Inhibitor Repression","volume":"21","author":"Lagger","year":"2002","journal-title":"EMBO J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1038\/sj.onc.1209473","article-title":"Histone Deacetylase 3 Localizes to the Plasma Membrane and Is a Substrate of Src","volume":"25","author":"Longworth","year":"2006","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","article-title":"Epigenetic Control of Skull Morphogenesis by Histone Deacetylase 8","volume":"23","author":"Haberland","year":"2009","journal-title":"Genes Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The Many Roles of Histone Deacetylases in Development and Physiology: Implications for Disease and Therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone Deacetylases (HDACs): Characterization of the Classical HDAC Family","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics Profiling of HDAC Inhibitors Reveals Selective Targeting of HDAC Complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","article-title":"Class II Histone Deacetylases: From Sequence to Function, Regulation, and Clinical Implication","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1101\/gad.14.1.45","article-title":"Nuclear Receptor Corepressors Partner with Class II Histone Deacetylases in a Sin3-Independent Repression Pathway","volume":"14","author":"Huang","year":"2000","journal-title":"Genes Dev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the Hidden Catalytic Activity of Vertebrate Class IIa Histone Deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone Deacetylase 6 Structure and Molecular Basis of Catalysis and Inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: A Key Regulator of Cytoskeleton, Cell Migration and Cell\u2013Cell Interactions","volume":"18","author":"Cabrero","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chang, P., Li, H., Hu, H., Li, Y., and Wang, T. (2021). The Role of HDAC6 in Autophagy and NLRP3 Inflammasome. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.763831"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1021\/acs.jmedchem.3c00314","article-title":"Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6","volume":"66","author":"Harding","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1021\/acs.jmedchem.8b00258","article-title":"Identification and Structure\u2013Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors","volume":"61","author":"Harding","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1021\/acs.jmedchem.2c00853","article-title":"First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation","volume":"65","author":"Yue","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","article-title":"The Development Prospection of HDAC Inhibitors as a Potential Therapeutic Direction in Alzheimer\u2019s Disease","volume":"6","author":"Yang","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13148-011-0025-7","article-title":"Targeting Huntington\u2019s Disease through Histone Deacetylases","volume":"2","author":"Gray","year":"2011","journal-title":"Clin. Epigenet."},{"key":"ref_33","first-page":"303294","article-title":"Targeting Histone Deacetylases: A Novel Approach in Parkinson\u2019s Disease","volume":"2015","author":"Sharma","year":"2015","journal-title":"Park. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2119\/molmed.2011.00077","article-title":"The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple Sclerosis","volume":"17","author":"Faraco","year":"2011","journal-title":"Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone Deacetylase Inhibitors: Overview and Perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone Deacetylases and Their Inhibitors in Cancer, Neurological Diseases and Immune Disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer Activities of Histone Deacetylase Inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ctrv.2005.12.006","article-title":"Histone Deacetylase Inhibitors: Multifunctional Anticancer Agents","volume":"32","author":"Liu","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cmdc.201300413","article-title":"Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next","volume":"9","author":"Thaler","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40265-015-0388-8","article-title":"Panobinostat: First Global Approval","volume":"75","year":"2015","journal-title":"Drugs"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat: First Global Approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1021\/jm0303094","article-title":"Histone Deacetylase Inhibitors","volume":"46","author":"Miller","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/acschemneuro.8b00620","article-title":"CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies","volume":"10","author":"Fuller","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2174\/156802612802652420","article-title":"Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease","volume":"12","author":"Gupta","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.bmcl.2010.03.091","article-title":"Exploration of the HDAC2 Foot Pocket: Synthesis and SAR of Substituted N-(2-Aminophenyl)Benzamides","volume":"20","author":"Bressi","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/jm4011884","article-title":"Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington\u2019s Disease","volume":"56","author":"Luckhurst","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1016\/j.bmcl.2009.08.010","article-title":"Diphenylmethylene Hydroxamic Acids as Selective Class IIa Histone Deacetylase Inhibitors","volume":"19","author":"Tessier","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal Structure of a Eukaryotic Zinc-Dependent Histone Deacetylase, Human HDAC8, Complexed with a Hydroxamic Acid Inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 Is a Microtubule-Associated Deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-Selective Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6)-Mediated Tubulin Deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/jm400390r","article-title":"Discovery of the First Histone Deacetylase 6\/8 Dual Inhibitors","volume":"56","author":"Olson","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jm301355j","article-title":"Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif","volume":"56","author":"Wagner","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual Zinc-Binding Mode of HDAC6-Selective Hydroxamate Inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Osko, J.D., and Christianson, D.W. (2020). Structural Determinants of Affinity and Selectivity in the Binding of Inhibitors to Histone Deacetylase 6. Bioorg. Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2020.127023"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors\u2014What Some May Have Forgotten or Would Rather Forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acsptsci.4c00031","article-title":"2-(Difluoromethyl)-1,3,4-Oxadiazoles: The Future of Selective Histone Deacetylase 6 Modulation?","volume":"7","author":"Hansen","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Cellupica, E., Caprini, G., Cordella, P., Cukier, C., Fossati, G., Marchini, M., Rocchio, I., Sandrone, G., Vanoni, M.A., and Vergani, B. (2023). Difluoromethyl-1,3,4-Oxadiazoles Are Slow-Binding Substrate Analog Inhibitors of Histone Deacetylase 6 with Unprecedented Isotype Selectivity. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2022.102800"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"14188","DOI":"10.1021\/acs.jmedchem.3c01269","article-title":"Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-Oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism","volume":"66","author":"Ripa","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1021\/acs.jmedchem.3c01345","article-title":"Difluoromethyl-1,3,4-Oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6","volume":"66","author":"Watson","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.32169","article-title":"Selective Pharmacological Inhibitors of HDAC6 Reveal Biochemical Activity but Functional Tolerance in Cancer Models","volume":"145","author":"Depetter","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the Crossroads between Cytoskeleton and Cell Signaling by Acetylation and Ubiquitination","volume":"26","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/med.21701","article-title":"Histone Deacetylases as Targets for the Treatment of Neurodegenerative Disorders: Challenges and Future Opportunities","volume":"40","author":"Rodrigues","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent Developments of HDAC Inhibitors: Emerging Indications and Novel Molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Brit. J. Clin. Pharma"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of Sodium Phenylbutyrate\u2013Taurursodiol for Amyotrophic Lateral Sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"148951","DOI":"10.1016\/j.brainres.2024.148951","article-title":"Class 1 Histone Deacetylases Differentially Modulate Memory and Synaptic Genes in a Spatial and Temporal Manner in Aged and APP\/PS1 Mice","volume":"1837","author":"McClarty","year":"2024","journal-title":"Brain Res."},{"key":"ref_68","unstructured":"Fuller, N.O., and Lowe, J.A. (2020). Bicyclic Inhibitors of Histone Deacetylase. (U.S. Patent 20200148678A1)."},{"key":"ref_69","unstructured":"Jefson, M.R., Lowe, J.A., Dey, F., Bergmann, A., Schoop, A., and Fuller, N.O. (2018). Hetero-Halo Inhibitors of Histone Deacetylase. (U.S. Patent 20180194769A1)."},{"key":"ref_70","unstructured":"Laria, J.C.P., G\u00f3mez, J.C., and Iglesias, R.R.I. (2022). New Heteroaryl Amide Derivatives as Selective Inhibitors of Histone Deacetylases 1 and 2 (HDAC1-2). (ZA202000727B)."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Hecklau, K., Mueller, S., Koch, S.P., Mehkary, M.H., Kilic, B., Harms, C., Boehm-Sturm, P., and Yildirim, F. (2021). The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington\u2019s Disease Mice. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.616886"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e2020293118","DOI":"10.1073\/pnas.2020293118","article-title":"Impaired Inhibitory GABAergic Synaptic Transmission and Transcription Studied in Single Neurons by Patch-Seq in Huntington\u2019s Disease","volume":"118","author":"Paraskevopoulou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2012.07.001","article-title":"RGFP109, a Histone Deacetylase Inhibitor Attenuates l-DOPA-Induced Dyskinesia in the MPTP-Lesioned Marmoset: A Proof-of-Concept Study","volume":"19","author":"Johnston","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Rai, M., Soragni, E., Chou, C.J., Barnes, G., Jones, S., Rusche, J.R., Gottesfeld, J.M., and Pandolfo, M. (2010). Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich\u2019s Ataxia Patients and in a Mouse Model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008825"},{"key":"ref_75","first-page":"4847","article-title":"Friedreich Ataxia-Induced Pluripotent Stem Cell-Derived Neurons Show a Cellular Phenotype That Is Corrected by a Benzamide HDAC Inhibitor","volume":"25","author":"Codazzi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.24260","article-title":"Epigenetic Therapy for F Riedreich Ataxia","volume":"76","author":"Soragni","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1021\/acschemneuro.0c00774","article-title":"Preclinical Evaluation of an18 F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain","volume":"12","author":"Tago","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00259-024-06666-1","article-title":"Preclinical Validation of a Novel Brain-Penetrant PET Ligand for Visualization of Histone Deacetylase 6: A Potential Imaging Target for Neurodegenerative Diseases","volume":"51","author":"Tago","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s41181-024-00277-9","article-title":"Step-by-Step Optimisation of the Radiosynthesis of the Brain HDAC6 Radioligand [18F]FSW-100 for Clinical Applications","volume":"9","author":"Tago","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1038\/s41467-022-30653-5","article-title":"[11C]Martinostat PET Analysis Reveals Reduced HDAC I Availability in Alzheimer\u2019s Disease","volume":"13","author":"Pascoal","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","article-title":"NAD+ Supplementation Reduces Neuroinflammation and Cell Senescence in a Transgenic Mouse Model of Alzheimer\u2019s Disease via cGAS\u2013STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","article-title":"Mitophagy in Alzheimer\u2019s Disease: Molecular Defects and Therapeutic Approaches","volume":"28","author":"Mary","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","article-title":"The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC and Fly Models of Parkinson\u2019s Disease","volume":"23","author":"Ivanyuk","year":"2018","journal-title":"Cell Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bcp.12512","article-title":"An Exploratory Double-blind, Randomized Clinical Trial with Selisistat, a SIRT1 Inhibitor, in Patients with H Untington\u2019s Disease","volume":"79","author":"Haider","year":"2015","journal-title":"Brit. J. Clin. Pharma"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Qin, P., Ran, Y., Xie, F., Liu, Y., Wei, C., Luan, X., and Wu, J. (2023). Design, Synthesis, and Biological Evaluation of Novel N-Benzyl Piperidine Derivatives as Potent HDAC\/AChE Inhibitors for Alzheimer\u2019s Disease. Bioorg. Med. Chem., 80.","DOI":"10.1016\/j.bmc.2023.117178"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17460441.2024.2322990","article-title":"Molecular Hybridization: A Powerful Tool for Multitarget Drug Discovery","volume":"19","author":"Franco","year":"2024","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/acschemneuro.3c00358","article-title":"Design, Synthesis, and Proof of Concept of Balanced Dual Inhibitors of Butyrylcholinesterase (BChE) and Histone Deacetylase 6 (HDAC6) for the Treatment of Alzheimer\u2019s Disease","volume":"14","author":"Wang","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/npp.2016.163","article-title":"A First-in-Class Small-Molecule That Acts as a Dual Inhibitor of HDAC and PDE5 and That Rescues Hippocampal Synaptic Impairment in Alzheimer\u2019s Disease Mice","volume":"42","author":"Rabal","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1021\/acs.jmedchem.6b00908","article-title":"Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer\u2019s Disease","volume":"59","author":"Rabal","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1021\/acschemneuro.9b00303","article-title":"Multitarget Approach for the Treatment of Alzheimer\u2019s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles","volume":"10","author":"Rabal","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acsmedchemlett.8b00507","article-title":"Discovery of the First-in-Class GSK-3\u03b2\/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer\u2019s Disease","volume":"10","author":"Betari","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"He, F., Ran, Y., Li, X., Wang, D., Zhang, Q., Lv, J., Yu, C., Qu, Y., Zhang, X., and Xu, A. (2020). Design, Synthesis and Biological Evaluation of Dual-Function Inhibitors Targeting NMDAR and HDAC for Alzheimer\u2019s Disease. Bioorg. Chem., 103.","DOI":"10.1016\/j.bioorg.2020.104109"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"117868","DOI":"10.1016\/j.ejmech.2025.117868","article-title":"Design, Synthesis and Pharmacological Evaluation of Multitarget GPR40 Agonists\/HDAC6 Inhibitors for Alzheimer\u2019s Disease","volume":"296","author":"Pinheiro","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1016\/j.bmc.2018.10.022","article-title":"Design, Synthesis, and Biological Evaluation of Histone Deacetylase Inhibitors Possessing Glutathione Peroxidase-like and Antioxidant Activities against Alzheimer\u2019s Disease","volume":"26","author":"Hu","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"110599","DOI":"10.1016\/j.celrep.2022.110599","article-title":"Direct Vascular Contact Is a Hallmark of Cerebral Astrocytes","volume":"39","author":"Zuend","year":"2022","journal-title":"Cell Rep."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"MacVicar, B.A., and Newman, E.A. (2015). Astrocyte Regulation of Blood Flow in the Brain. Cold Spring Harb. Perspect. Biol., 7.","DOI":"10.1101\/cshperspect.a020388"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Stackhouse, T.L., and Mishra, A. (2021). Neurovascular Coupling in Development and Disease: Focus on Astrocytes. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.702832"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41467-022-28331-7","article-title":"Physiological Synaptic Activity and Recognition Memory Require Astroglial Glutamine","volume":"13","author":"Cheung","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.neuron.2013.12.026","article-title":"A Local Glutamate-Glutamine Cycle Sustains Synaptic Excitatory Transmitter Release","volume":"81","author":"Tani","year":"2014","journal-title":"Neuron"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2004.12.020","article-title":"Thrombospondins Are Astrocyte-Secreted Proteins That Promote CNS Synaptogenesis","volume":"120","author":"Christopherson","year":"2005","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"E440","DOI":"10.1073\/pnas.1104977108","article-title":"Control of Excitatory CNS Synaptogenesis by Astrocyte-Secreted Proteins Hevin and SPARC","volume":"108","author":"Kucukdereli","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"41432","DOI":"10.1074\/jbc.M112.380824","article-title":"Astrocyte-Induced Synaptogenesis Is Mediated by Transforming Growth Factor \u03b2 Signaling through Modulation of d-Serine Levels in Cerebral Cortex Neurons","volume":"287","author":"Diniz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature11059","article-title":"Astrocyte Glypicans 4 and 6 Promote Formation of Excitatory Synapses via GluA1 AMPA Receptors","volume":"486","author":"Allen","year":"2012","journal-title":"Nature"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS Synaptogenesis Promoted by Glia-Derived Cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12035-016-0343-z","article-title":"Heterogeneity in Synaptogenic Profile of Astrocytes from Different Brain Regions","volume":"55","author":"Buosi","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.stemcr.2018.12.017","article-title":"Region-Restrict Astrocytes Exhibit Heterogeneous Susceptibility to Neuronal Reprogramming","volume":"12","author":"Hu","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive Astrocytes: Production, Function, and Therapeutic Potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Normal Aging Induces A1-like Astrocyte Reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41467-020-17514-9","article-title":"Knockout of Reactive Astrocyte Activating Factors Slows Disease Progression in an ALS Mouse Model","volume":"11","author":"Guttenplan","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Taylor, X., Cisternas, P., Jury, N., Martinez, P., Huang, X., You, Y., Redding-Ochoa, J., Vidal, R., Zhang, J., and Troncoso, J. (2022). Activated Endothelial Cells Induce a Distinct Type of Astrocytic Reactivity. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03237-8"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"682.4","DOI":"10.1096\/fasebj.31.1_supplement.682.4","article-title":"The Extracellular Matrix Proteoglycan Decorin Is Upregulated by Endothelial Cells During Inflammation and Contributes to Blood-Brain Barrier Dysfunction","volume":"31","author":"Hoettels","year":"2017","journal-title":"FASEB J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s43587-022-00257-1","article-title":"A Distinct Astrocyte Subtype in the Aging Mouse Brain Characterized by Impaired Protein Homeostasis","volume":"2","author":"Lee","year":"2022","journal-title":"Nat. Aging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","article-title":"Astrocytes and Oligodendrocytes Undergo Subtype-Specific Transcriptional Changes in Alzheimer\u2019s Disease","volume":"110","author":"Sadick","year":"2022","journal-title":"Neuron"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e14493","DOI":"10.1111\/acel.14493","article-title":"Astrocytic Hevin\/SPARCL-1 Regulates Cognitive Decline in Pathological and Normal Brain Aging","volume":"24","author":"Araujo","year":"2025","journal-title":"Aging Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-Associated Astrocytes in Alzheimer\u2019s Disease and Aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41593-024-01669-5","article-title":"Apolipoprotein E in Alzheimer\u2019s Disease Trajectories and the next-Generation Clinical Care Pathway","volume":"27","author":"Narasimhan","year":"2024","journal-title":"Nat. Neurosci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41593-023-01288-6","article-title":"Lipid-Accumulated Reactive Astrocytes Promote Disease Progression in Epilepsy","volume":"26","author":"Chen","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"102580","DOI":"10.1016\/j.arr.2024.102580","article-title":"Astrocytic Proteostasis in the Tale of Aging and Neurodegeneration","volume":"103","author":"Matias","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","article-title":"Astrocytic Autophagy Plasticity Modulates A\u03b2 Clearance and Cognitive Function in Alzheimer\u2019s Disease","volume":"19","author":"Kim","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson\u2019s Disease","volume":"12","author":"Carola","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-025-00796-2","article-title":"Upregulated Astrocyte HDAC7 Induces Alzheimer-like Tau Pathologies via Deacetylating Transcription Factor-EB and Inhibiting Lysosome Biogenesis","volume":"20","author":"Ye","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e2303809120","DOI":"10.1073\/pnas.2303809120","article-title":"Astrocyte-Targeting Therapy Rescues Cognitive Impairment Caused by Neuroinflammation via the Nrf2 Pathway","volume":"120","author":"Canela","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"13574","DOI":"10.1523\/JNEUROSCI.4099-08.2008","article-title":"Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis","volume":"28","author":"Vargas","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12975-011-0087-z","article-title":"Expression of Histone Deacetylases in Cellular Compartments of the Mouse Brain and the Effects of Ischemia","volume":"2","author":"Baltan","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1073\/pnas.0407643101","article-title":"Histone Deacetylase Inhibition-Mediated Neuronal Differentiation of Multipotent Adult Neural Progenitor Cells","volume":"101","author":"Hsieh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.devcel.2016.01.002","article-title":"Hdac3 Interaction with P300 Histone Acetyltransferase Regulates the Oligodendrocyte and Astrocyte Lineage Fate Switch","volume":"36","author":"Zhang","year":"2016","journal-title":"Dev. Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1523\/JNEUROSCI.22-23-10333.2002","article-title":"Histone Deacetylase Activity Is Necessary for Oligodendrocyte Lineage Progression","volume":"22","author":"Muggironi","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/febs.12079","article-title":"Histone Deacetylase 6 Plays a Role as a Distinct Regulator of Diverse Cellular Processes","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/glia.22865","article-title":"HDAC 6 Mediates HIV-1 Tat-induced Proinflammatory Responses by Regulating MAPK-NF-kappa B\/AP-1 Pathways in Astrocytes","volume":"63","author":"Youn","year":"2015","journal-title":"Glia"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Beurel, E. (2011). HDAC6 Regulates LPS-Tolerance in Astrocytes. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025804"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1007\/s12035-022-02965-6","article-title":"HDAC7 Activates IKK\/NF-\u03baB Signaling to Regulate Astrocyte-Mediated Inflammation","volume":"59","author":"Ye","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_133","first-page":"4368","article-title":"Histone Acetylation in Astrocytes Suppresses GFAP and Stimulates a Reorganization of the Intermediate Filament Network","volume":"127","author":"Kanski","year":"2014","journal-title":"J. Cell Sci."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Bailey, Z.S., Grinter, M.B., and VandeVord, P.J. (2016). Astrocyte Reactivity Following Blast Exposure Involves Aberrant Histone Acetylation. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00064"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Mancino, S., Boraso, M., Galmozzi, A., Serafini, M.M., De Fabiani, E., Crestani, M., and Viviani, B. (2025). Dose-Dependent Dual Effects of HDAC Inhibitors on Glial Inflammatory Response. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-96241-x"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1742-2094-9-113","article-title":"The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Attenuates Human Astrocyte Neurotoxicity Induced by Interferon-\u03b3","volume":"9","author":"Hashioka","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Dresselhaus, E., Duerr, J.M., Vincent, F., Sylvain, E.K., Beyna, M., Lanyon, L.F., LaChapelle, E., Pettersson, M., Bales, K.R., and Ramaswamy, G. (2018). Class I HDAC Inhibition Is a Novel Pathway for Regulating Astrocytic apoE Secretion. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194661"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","article-title":"Amyloid Clearance Defect in ApoE4 Astrocytes Is Reversed by Epigenetic Correction of Endosomal pH","volume":"115","author":"Prasad","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","article-title":"Histone Deacetylase Inhibition Alters Histone Methylation Associated with Heat Shock Protein 70 Promoter Modifications in Astrocytes and Neurons","volume":"60","author":"Marinova","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"pyw035","DOI":"10.1093\/ijnp\/pyw035","article-title":"Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3","volume":"19","author":"Leng","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1074\/jbc.M200527200","article-title":"Transcriptional Regulation of Cyclooxygenase-1 by Histone Deacetylase Inhibitors in Normal Human Astrocyte Cells","volume":"277","author":"Taniura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/JVI.03333-13","article-title":"Epigenetic Regulation of HIV-1 Latency in Astrocytes","volume":"88","author":"Narasipura","year":"2014","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2013.07.007","article-title":"Dimethyl Fumarate Regulates Histone Deacetylase Expression in Astrocytes","volume":"263","author":"Kalinin","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1523\/JNEUROSCI.5379-10.2011","article-title":"Histone Deacetylase Inhibitors Preserve White Matter Structure and Function during Ischemia by Conserving ATP and Reducing Excitotoxicity","volume":"31","author":"Baltan","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone Deacetylase Inhibitors Up-Regulate Astrocyte GDNF and BDNF Gene Transcription and Protect Dopaminergic Neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11481-010-9192-0","article-title":"Histone Deacetylase Inhibitors Suppress the Expression of Inflammatory and Innate Immune Response Genes in Human Microglia and Astrocytes","volume":"5","author":"Suh","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/WNR.0b013e328308b355","article-title":"Enhancement of Glutamate Uptake in 1-Methyl-4-Phenylpyridinium-Treated Astrocytes by Trichostatin A","volume":"19","author":"Wu","year":"2008","journal-title":"NeuroReport"},{"key":"ref_148","first-page":"17","article-title":"Histone Deacetylases Regulation by \u03b4-Opioids in Human Optic Nerve Head Astrocytes","volume":"61","author":"Zaidi","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Soltan, O.M., Abdelrahman, K.S., Bass, A.K.A., Takizawa, K., Narumi, A., and Konno, H. (2024). Design of Multi-Target Drugs of HDACs and Other Anti-Alzheimer Related Targets: Current Strategies and Future Prospects in Alzheimer\u2019s Diseases Therapy. Bioorg. Chem., 151.","DOI":"10.1016\/j.bioorg.2024.107651"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41419-025-07569-1","article-title":"Generation and Validation of a Novel Multitarget Small Molecule in Glioblastoma","volume":"16","author":"Elizazu","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"148847","DOI":"10.1016\/j.brainres.2024.148847","article-title":"Study on Multi-Target Effects of the Novel HDAC6 Inhibitor W5 on A\u03b2\/Cu2+-Induced Alzheimer\u2019s Disease Model of Rats","volume":"1832","author":"Liu","year":"2024","journal-title":"Brain Res."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/10\/1471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:03:46Z","timestamp":1762178626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/10\/1471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":151,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ph18101471"],"URL":"https:\/\/doi.org\/10.3390\/ph18101471","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}